Intcomex, Inc.

CIK:0001359425|SEC Filings

Fair Value of Derivative Instruments - Summary of Location and Amounts of Loss in Condensed Statements of Operations and Comprehensive (Loss) Income Related to Derivative Instruments (Detail) (Foreign Currency Contracts [Member], USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Derivative Instruments, Gain (Loss) [Line Items]
Derivative instrument (gain) loss in period			$ 66
Other Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative instrument (gain) loss in period			$ 66

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net (loss) income	$ (9,331)	$ 3,796
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:
Share-based compensation expense	327	249
Depreciation expense	2,804	2,951
Amortization expense of debt issuance costs and discount	2,119	1,896
Amortization expense of identifiable intangible assets	310	506
Bad debt expense	1,472	1,110
Inventory obsolescence expense	80	4,578
Deferred income tax benefit	(343)	(1,912)
Gain on sale of subsidiary	(375)
Gain on termination of non-compete agreement		(4,285)
Loss on extinguishment of long-term debt		23
Loss on disposal of property and equipment and other	150	13
Decrease (increase) in:
Trade accounts receivables	22,123	468
Inventories	7,655	(3,210)
Prepaid expenses, notes receivable and other	5,455	(6,457)
Due from related parties	(137)	(405)
(Decrease) increase in:
Accounts payable	(15,869)	(14,897)
Accrued expenses and other	2,006	(846)
Due to related parties	(7)
Net cash provided by (used in) operating activities	18,439	(16,422)
Cash flows from investing activities:
Purchases of property and equipment	(2,018)	(2,392)
Proceeds from termination of non-compete agreement		5,000
Proceeds from sale of subsidiary	506
Proceeds from notes receivable and other	24	345
Proceeds from disposition of assets	112	38
Net cash (used in) provided by investing activities	(1,376)	2,991
Cash flows from financing activities:
(Payments) borrowings under lines of credit, net	(1,627)	13,755
Proceeds from borrowings under long-term debt	32	355
Payments of long-term debt	(307)	(1,558)
Net cash (used in) provided by financing activities	(1,902)	12,552
Effect of foreign currency exchange rate changes on cash and cash equivalents	(242)	(67)
Net increase (decrease) in cash and cash equivalents	14,919	(946)
Cash and cash equivalents, beginning of period	30,586	25,707
Cash and cash equivalents, end of period	45,505	24,761
Non-cash investing and financing activities:
Property acquired through financing	$ 818

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Current assets
Cash and cash equivalents	$ 45,505	$ 30,586
Restricted cash	235	226
Trade accounts receivable (net of allowance for doubtful accounts of $7,529 and $5,944 at September 30, 2013 and December 31, 2012, respectively)	118,777	142,431
Inventories	155,658	163,355
Prepaid expenses, notes receivable and other	67,777	73,543
Due from related parties	639	505
Total current assets	388,591	410,646
Property and equipment, net	14,442	14,598
Goodwill	18,034	18,069
Identifiable intangible assets	635	906
Notes receivable and other	17,699	17,983
Total assets	439,401	462,202
Current liabilities
Lines of credit	48,394	50,021
Current maturities of long-term debt	10,172	10,253
Accounts payable	196,421	212,210
Accrued expenses and other	23,860	21,665
Due to related parties	33	40
Total current liabilities	278,880	294,189
Long-term debt, net of current maturities	99,052	97,455
Other long-term liabilities	4,054	4,083
Total liabilities	381,986	395,727
Commitments and contingencies
Shareholders' equity
Common stock, voting $0.01 par value, 200,000 shares authorized, 168,816 shares issued and 167,947 outstanding	2	2
Additional paid in capital	64,389	64,062
Treasury stock, 869 shares	(508)	(508)
Retained earnings	(1,575)	7,756
Accumulated other comprehensive loss	(4,893)	(4,837)
Total shareholders' equity	57,415	66,475
Total liabilities and shareholders' equity	$ 439,401	$ 462,202